Refractory or Recurrent Solid Tumors
2 clinical trials · Condition
◉ Watch Refractory or Recurrent Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors (NCT03245450) | Eisai Inc. | 2018-03-05 |
| AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia (NCT00321581) | National Cancer Institute (NCI) | 2006-05-01 |
Track Refractory or Recurrent Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.